In lung cancer, epidermal growth factor receptor (EGFR) and KRAS mutations occur frequently in adenocarcinoma, rarely in squamous cell carcinoma and hardly ever in small cell carcinoma (1–3). The gene discussed is EGFR; the disease is adenocarcinoma.